a woman looking to the right and slightly smiling

Creating new possibilities for mental health patients

We are a clinical-stage biopharmaceutical company developing new mental health treatments to transform patient outcomes.

About us Programs

Focusing where the most people have the fewest options

We focus on mental health disorders where patients have limited or no effective treatment options.

Therapeutic areas

a woman looking to the left and slightly smiling

Depression

a woman looking to the right and slightly smiling

Social anxiety disorder

a man looking to the right and slightly smiling

Cognitive impairment associated with schizophrenia

a man looking to the left and slightly smiling

atai team

Programs

Developing patient-first, evidence-based therapies

We aim to develop rapid-acting, effective and durable mental health treatments for large-scale patient impact.

Programs & research

Team

Leading with empathy, backed by deep expertise

Our diverse and dedicated team of leading experts and scientists is united by a common goal: to transform mental health care for patients.

Leadership team

atai Life Sciences Reports Third Quarter 2024 Financial Results and Provides Corporate Updates

atai Life Sciences to Participate in the 2024 Maxim Healthcare Virtual Summit

atai Life Sciences to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

In the news

Media